{"id":"https://openalex.org/W2603225534","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7513","title":"CALGB 30704: A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small cell lung cancer (NSCLC).","display_name":"CALGB 30704: A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small cell lung cancer (NSCLC).","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2603225534","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7513","mag":"2603225534"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.7513","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7513","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.7513","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064382279","display_name":"Rebecca Suk Heist","orcid":"https://orcid.org/0000-0002-7397-2009","observed_orcids":["https://orcid.org/0000-0002-7397-2009"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Suk Heist","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075123627","display_name":"Xiaofei F. Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaofei F. Wang","raw_affiliation_strings":["Cancer and Leukemia Group B Statistical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer and Leukemia Group B Statistical Center, Durham, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110096364","display_name":"Lydia C. Hodgson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lydia Hodgson","raw_affiliation_strings":["Duke University, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004712121","display_name":"Gregory A. Otterson","orcid":"https://orcid.org/0000-0001-9877-8512","observed_orcids":["https://orcid.org/0000-0001-9877-8512"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Alan Otterson","raw_affiliation_strings":["Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014554706","display_name":"Thomas E. Stinchcombe","orcid":"https://orcid.org/0000-0002-3595-8011","observed_orcids":["https://orcid.org/0000-0002-3595-8011"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Stinchcombe","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063904421","display_name":"Everett E. Vokes","orcid":"https://orcid.org/0000-0002-8645-8068","observed_orcids":["https://orcid.org/0000-0002-8645-8068"]},"institutions":[{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Everett E. Vokes","raw_affiliation_strings":["The University of Chicago Medical Center, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago Medical Center, Chicago, IL","institution_ids":["https://openalex.org/I4210087865"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Socinski","raw_affiliation_strings":["University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210134769"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"7513","last_page":"7513"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.027799999341368675,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.8209999799728394},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8659999966621399},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.9660000205039978},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9610000252723694},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7760000228881836},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6349999904632568},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.8429999947547913},{"id":"https://openalex.org/keywords/non-hematologic-toxicity","display_name":"non-hematologic toxicity","score":0.8130000233650208},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.3919999897480011},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5849999785423279},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5490000247955322},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.4869999885559082},{"id":"https://openalex.org/keywords/prognostic-model","display_name":"prognostic model","score":0.31299999356269836}],"concepts":[{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.9307621717453003},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9037249088287354},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.6799582839012146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6749585270881653},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5953788161277771},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5050449967384338},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.48324689269065857},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4627753496170044},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4484982192516327},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4374730885028839},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.419897198677063},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36402326822280884},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3200327754020691},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.19221442937850952}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.7513","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7513","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.7513","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2050516646","https://openalex.org/W4213195668","https://openalex.org/W2563376698","https://openalex.org/W2250110944","https://openalex.org/W3149225208","https://openalex.org/W2369594532","https://openalex.org/W2244156441","https://openalex.org/W2791905615","https://openalex.org/W2946384932","https://openalex.org/W2385402256"],"abstract_inverted_index":{"7513":[0],"Background:":[1],"Second":[2],"line":[3],"chemotherapy":[4,29,45],"improves":[5],"survival":[6],"modestly":[7],"and":[8,80,94,113,309],"new":[9],"strategies":[10],"are":[11],"needed.":[12],"This":[13],"trial":[14],"was":[15,85,98,102,147,152,156,241,259,312],"designed":[16],"to":[17,50,106,301,319],"evaluate":[18],"the":[19,131,159,197,220,279,305,320],"paradigm":[20],"of":[21,307],"an":[22,212],"anti-VEGF":[23],"strategy":[24],"with":[25,36,225,315,324],"or":[26,61,291,304],"without":[27],"standard":[28],"in":[30,130,158,196,217,278],"previously":[31],"treated":[32,120],"NSCLC.":[33],"Methods:":[34],"Patients":[35],"Stage":[37,143],"IIIB/IV":[38],"NSCLC,":[39],"PS":[40,76,140],"0-1":[41],"progressive":[42],"after":[43],"first-line":[44],"were":[46,73,91,135],"eligible":[47],"for":[48,230,237,245,250,255,263,268,273,328],"randomization":[49],"P":[51,166,183,201,289,316],"(pemetrexed":[52,63],"500":[53,64],"mg/m2":[54,65],"d1),":[55],"S":[56,169,186,204,292],"(sunitinib":[57],"37.5":[58,69],"mg":[59,70],"d1-21),":[60],"P+S":[62,172,189,207,274,280,325],"d1":[66],"+":[67],"sunitinib":[68,303],"d1-21).":[71],"Pts":[72],"stratified":[74],"by":[75],"(0/1),":[77],"stage":[78],"(IIIB/IV),":[79],"gender":[81],"(M/F).":[82],"Primary":[83],"objective":[84],"18-week":[86,193],"PFS":[87,194,258],"rate;":[88],"secondary":[89],"objectives":[90],"response,":[92],"OS,":[93],"toxicity.":[95],"Target":[96],"accrual":[97,108],"225.":[99],"The":[100,192],"study":[101],"terminated":[103],"early":[104],"due":[105],"decreasing":[107],"rates.":[109],"Results:":[110],"Between":[111],"4/08":[112],"9/11,":[114],"130":[115],"pts":[116,119],"registered;":[117],"128":[118],"(P=41,":[121],"S=46,":[122],"P+S=41).":[123],"Median":[124,239,257],"follow-up":[125],"99":[126],"weeks.":[127],"Baseline":[128],"characteristics":[129],"three":[132,198,221],"arms":[133,199,222],"(P/S/P+S)":[134],"well":[136],"balanced:":[137],"Male":[138],"(54%/54%/54%);":[139],"0":[141],"(32%/35%/34%);":[142],"IV":[144],"(88%/83%/93%).":[145],"Histology":[146],"predominantly":[148],"adenocarcinoma":[149],"(66%/57%/66%);":[150],"squamous":[151],"allowed":[153],"(10%/15%/15%).":[154],"Toxicity":[155],"higher":[157],"S-containing":[160,322],"arms:":[161],"Grade":[162,175],"3/4/5":[163,176],"hematologic":[164],"toxicity:":[165],"5/0/0":[167],"(12%),":[168],"8/1/0":[170],"(21%),":[171],"5/9/0":[173],"(36%);":[174],"non-hematologic":[177],"toxicity":[178,299],"(excluding":[179],"disease":[180],"related":[181],"deaths):":[182],"6/2/0":[184],"(20%),":[185],"21/3/1":[187,190],"(58%),":[188],"(63%).":[191],"rate":[195],"was:":[200],"51%":[202],"(38-69),":[203],"36%":[205],"(24-54),":[206],"47%":[208],"(34-65).":[209],"There":[210],"is":[211],"overall":[213],"statistically":[214],"significant":[215],"difference":[216],"OS":[218,240,311],"between":[219],"(2-sided":[223],"p=0.0179)":[224],"HR":[226,232],"0.65":[227],"(95%CI:":[228,234],"0.38-1.13)":[229],"P/S;":[231],"0.47":[233],"0.27-":[235],"0.82)":[236],"P/P+S.":[238],"10.5":[242],"mo":[243,248,254,261,266,271],"(8.3-22.5)":[244],"P,":[246,264],"7.0":[247],"(6.0-13.0)":[249],"S,":[251,269],"6.7":[252],"(4.1-10.4)":[253],"P+S.":[256],"4.4":[260],"(1.7-8.8)":[262],"3.3":[265],"(2.7-4.3)":[267],"3.7":[270],"(2.5-4.3)":[272],"(p=0.3).":[275],"Fewer":[276],"patients":[277],"arm":[281],"received":[282],"any":[283],"subsequent":[284],"therapy":[285],"(29%)":[286],"than":[287],"either":[288,302],"(54%)":[290],"(57%).":[293],"Conclusions:":[294],"Pemetrexed":[295],"had":[296],"a":[297],"superior":[298],"profile":[300],"combination":[306],"pemetrexed":[308],"sunitinib.":[310],"significantly":[313],"better":[314],"alone":[317],"compared":[318],"two":[321],"arms,":[323],"performing":[326],"worst":[327],"OS.":[329]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-04-07T00:00:00"}